Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response

Recent reports have revealed that oncolytic viruses (OVs) play a significant role in cancer therapy. The infection of OVs such as oncolytic vaccinia virus (OVV), vesicular stomatitis virus (VSV), parvovirus, mammalian reovirus (MRV), human adenovirus, Newcastle disease virus (NDV), herpes simplex vi...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cellular and infection microbiology Vol. 13; p. 1142172
Main Authors Wu, Yi-Ying, Sun, Te-Kai, Chen, Ming-Shan, Munir, Muhammad, Liu, Hung-Jen
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 15.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent reports have revealed that oncolytic viruses (OVs) play a significant role in cancer therapy. The infection of OVs such as oncolytic vaccinia virus (OVV), vesicular stomatitis virus (VSV), parvovirus, mammalian reovirus (MRV), human adenovirus, Newcastle disease virus (NDV), herpes simplex virus (HSV), avian reovirus (ARV), Orf virus (ORFV), inactivated Sendai virus (ISV), enterovirus, and coxsackievirus offer unique opportunities in immunotherapy through diverse and dynamic pathways. This mini-review focuses on the mechanisms of OVs-mediated virotherapy and their effects on immunogenic cell death (ICD), apoptosis, autophagy and regulation of the immune system.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Zong Sheng Guo, University at Buffalo, United States
This article was submitted to Virus and Host, a section of the journal Frontiers in Cellular and Infection Microbiology
Edited by: Masmudur Mohammed Rahman, Arizona State University, United States
ISSN:2235-2988
2235-2988
DOI:10.3389/fcimb.2023.1142172